Express News | VTv Therapeutics: In 2Nd Amendment, on Newsoara Payment of $20 Mln Upfront Fee, Original License to Be Expanded to Global License

Reuters16:44 ET

Express News | VTv Therapeutics: Got Into Second Amendment to License Agreement With Newsoara Biopharma Co

Reuters16:43 ET

Express News | VTv Therapeutics Announces Screening of First Patient in Catt1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes

ReutersJun 24 16:05 ET

VTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes

PDF Version Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by the FDA for T1DCadisegliatin h

vTv TherapeuticsJun 24 00:00 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersLongeveron (NASDAQ:LGVN) shares rose 112.1% to $1.74 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. vTv Therapeutics (NASDAQ:VTVT) stock i

BenzingaJun 12 12:31 ET

Goldman Sachs Raises Obesity Drug Market Estimate to $130B

Seeking AlphaMay 30 11:22 ET